首页> 外文期刊>Investigational new drugs. >Growth inhibition and apoptosis-induced effect on human cancer cells of toosendanin, a triterpenoid derivative from chinese traditional medicine.
【24h】

Growth inhibition and apoptosis-induced effect on human cancer cells of toosendanin, a triterpenoid derivative from chinese traditional medicine.

机译:太生丹宁是一种中药的三萜类衍生物,对人癌细胞具有抑制生长和凋亡的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Toosendanin, a triterpenoid derivative isolated from the barks of Melia toosendan Sieb et Zucc, has been used as an anthelmintic vermifuge against ascaris for more than fifty years in China. In the present study, we investigated the growth inhibition and apoptosis-induced effect of toosendanin on human cancer cells. The result showed that toosendanin significantly suppressed the proliferation of tested human cancer cell lines. The IC(50) values were less than 1.7 x 10(-7) M and U937 was the most sensitive cell line with a IC(50) of 5.4 x 10(-9) M. Flow cytometric analysis revealed that treatment of U937 cells with toosendanin resulted in a dose- and time-dependent accumulation of cells in the S phase with a concomitant decrease in cells processing to G(0)/G(1) phase. The growth inhibition of U937 cells after exposure to toosendanin was subsequently associated with the induction of apoptosis, as evidence by the typical condensed and fragmented nuclei, DNA fragmentation, and exposure of phosphatidylserine on the outer leaflet of plasma membrane. All these results indicated that toosendanin could serve as a potential candidate for anticancer drug.
机译:甲苯磺胺黄酮(一种从三味Mel(Melia toosendan Sieb et Zucc)的树皮中分离出的三萜类衍生物)在中国已被用作驱除a虫的驱虫药。在本研究中,我们研究了太生丹宁对人癌细胞的生长抑制和凋亡诱导的作用。结果表明,太参丹宁显着抑制了所测试的人类癌细胞系的增殖。 IC(50)值小于1.7 x 10(-7)M,U937是最敏感的细胞系,IC(50)为5.4 x 10(-9)M。流式细胞仪分析显示,对U937细胞的处理太丹丹宁的使用导致S期细胞的剂量和时间依赖性积累,伴随而来的是细胞加工到G(0)/ G(1)期的减少。暴露于过少的丹参素后,U937细胞的生长抑制随后与细胞凋亡的诱导相关,如典型的核浓缩和断裂,DNA断裂以及磷脂酰丝氨酸暴露于质膜外小叶所证明。所有这些结果表明,太参丹宁可以作为抗癌药物的潜在候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号